Wednesday, June 25, 2014

Shire wins in DNJ in case over the hyperactivity drug Vyvanse



Reuters noted that DNJ granted Shire's summary judgment motion in a lawsuit against five generic drug producers [ Actavis, Amneal, Mylan, Roxane and Novartis's Sandoz unit ], holding that patent claims protecting its medicine were both infringed and valid.

link: http://in.reuters.com/article/2014/06/25/shire-vyvanse-idINFWN0OZ04720140625

0 Comments:

Post a Comment

<< Home